series-a
Stage
2022
Founded
1
Investors
About
Vilya is a computational biotechnology company that uses advanced machine learning and AI-driven design to create novel macrocyclic drugs targeting disease biology, aiming to design new molecular structures not found in nature to precisely address previously intractable medical challenges.
Explore Vilya's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.